Chemoenzymatic site-selective attachment to antibodies: using glycosylation sites to post-translationally program function

Chemoenzymatic site-selective attachment to antibodies: using glycosylation sites to post-translationally program function

Detaylı Bibliyografya
Yazar:	Khan, MA
Diğer Yazarlar:	Davis, B
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	2021
Konular:	Chemical biology Antibody Glycobiology Chemistry Bispecific antibodies

Benzer Materyaller

The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites
Yazar:: Elizabeth A. Lampros, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Investigations into novel enzymatic glycosylation methods
Yazar:: Taylor, T
Baskı/Yayın Bilgisi: (2015)

Investigating the N-linked glycan specificity of bacterial endo-beta-N-acetylglucosaminidase S
Yazar:: Goodfellow, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Bispecific antibodies: design, therapy, perspectives
Yazar:: Sedykh SE, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Bispecific antibodies and their use in applied research
Yazar:: Harshit Verma, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach
Yazar:: Ruben T. Almaraz, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
Yazar:: Suheil Albert Atallah-Yunes, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
Yazar:: Hyunbo Shim
Baskı/Yayın Bilgisi: (2020-02-01)

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Yazar:: Gihoon You, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
Yazar:: Patrick Willard, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Bispecific antibody drug conjugates: Making 1+1>2
Yazar:: Yilin Gu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues
Yazar:: Francis M. Barnieh, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy
Yazar:: Doina Atanasiu, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Yazar:: Masaud Shah, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Incorporation of trehalose analogues into Mycobacterium Tuberculosis: antigen 85 and probes of bacterial infection
Yazar:: Backus, K
Baskı/Yayın Bilgisi: (2011)

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
Yazar:: Pan H, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Yazar:: Ku, Zhiqiang, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
Yazar:: Karie Runcie, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
Yazar:: Kevin E. Ramos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities
Yazar:: Xianglei Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Modified Therapeutic Antibodies: Improving Efficacy
Yazar:: Ji-Min Dai, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Inhibitory superagonistic antibodies as novel therapeutics
Yazar:: Donat, RF
Baskı/Yayın Bilgisi: (2023)

Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
Yazar:: Caitlin Fawcett, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Yazar:: Monica L. Fernández-Quintero, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
Yazar:: Waqqas Tai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
Yazar:: Monica L. Fernández-Quintero, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Bispecific antibodies: a novel approach for targeting prominent biomarkers
Yazar:: Akshita Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
Yazar:: Gabriele Antonarelli, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
Yazar:: Emilia Rabia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Bispecific antibodies for viral immunotherapy
Yazar:: Elisabeth K. Nyakatura, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Antigenic and immunomodulatory properties of HIV-1 gp120 N-linked glycosylation
Yazar:: Bonomelli, C
Baskı/Yayın Bilgisi: (2013)

One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa/CD16a structure
Yazar:: Paul G Kremer, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
Yazar:: Glawar, AFG
Baskı/Yayın Bilgisi: (2013)

Emerging Antibodies in Cancer Therapy
Yazar:: Yaping Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Editorial: Therapeutic antibody domains against cancer
Yazar:: Qi Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
Yazar:: S. E. Sedykh, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Intein mediated high throughput screening for bispecific antibodies
Yazar:: Tim Hofmann, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Injection site reaction to teclistamab in a patient with multiple myeloma
Yazar:: Isabel C. Yoon, BS, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Editorial: Endo- and transcytotic pathways at the brain barriers
Yazar:: Michelle A. Erickson, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
Yazar:: Rita Tavarozzi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)